LARIMAR THERAPEUTICS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $14.3M | $78.7M | $70.1M |
| FY2022 | $15.5M | $126.4M | $26.8M |
| FY2023 | $14.2M | $95.9M | $26.7M |
| FY2024 | $28.4M | $200.2M | $33.2M |
| FY2025 | $67.8M | $145.8M | $85.4M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $14.3M | $78.7M | $70.1M |
| FY2022 | $15.5M | $126.4M | $26.8M |
| FY2023 | $14.2M | $95.9M | $26.7M |
| FY2024 | $28.4M | $200.2M | $33.2M |
| FY2025 | $67.8M | $145.8M | $85.4M |